We did not detect the expression of PD-L1/2 on ID8 tumor cells, which may partially explain the refractoriness of ID8 tumor to anti-PD-1 mAb alone as the findings from clinical trials show the correlation between PD-L1 expression on the tumor with the response to anti-PD-1 mAb [20]. Here, CD274 is linked to neoplasm.